Abstract

Bezold abscess (BA) can be a rare complication of different forms of otitis media. We describe a rare case of BA determined by Escherichia Coli. Because of COVID-19 restriction, the surgery had to be delayed up to the swab results. To avoid infection spread, the patient was treated by blind antibiotic treatment until the surgical drainage of mastoid and neck. Thanks to the treatment with broad-spectrum antibiotics, the progression and the spread of the infection during COVID-19 investigation was avoided. Delayed surgery could expose the patient to the risk of severe brain infection caused by the E. Coli.

Details

Title
How can we manage Bezold abscess emergency in COVID-19 pandemic? Blind ceftriaxone and metronidazole treatment to avoid infection spread†
Author
Scarpa, Alfonso 1 ; Arianna Di Stadio 2 ; De Luca, Pietro 1   VIAFID ORCID Logo  ; Calvanese, Matteo 1 ; Viola, Pasquale 3   VIAFID ORCID Logo  ; Tassone, Domenico 4 ; de Campora, Luca 4 ; Simone, Matteo 4 ; Ricci, Giampietro 2 ; Messineo, Daniela 5 ; Ralli, Massimo 6 ; Cassandro, Claudia 7 

1  Department of Medicine , Surgery and Dentistry, University of Salerno, Salerno, Italy 
2  Department of Otolaryngology , University of Perugia, Perugia, Italy 
3  Department of Experimental and Clinical Medicine , Unit of Audiology, Regional Centre for Cochlear Implants and ENT Diseases, Magna Graecia University, Catanzaro, Italy 
4  Otolaryngology Department , San Giovanni-Addolorata Hospital, Rome, Italy 
5  Radiology Oncology and Anatomopathological Department , University La Sapienza, Rome, Italy 
6  Organ of Sense Department , University La Sapienza, Rome, Italy 
7  Department of Otolaryngology , University of Turin, Turin, Italy 
Publication year
2021
Publication date
Oct 2021
Publisher
Oxford University Press
e-ISSN
20428812
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1093/jscr/rjab493
ProQuest document ID
3170798812
Copyright
Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2021. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.